Showing 1 - 8 results of 8 for search '"DNDi"', query time: 0.23s Refine Results
  1. 1
    Drug discovery and development for neglected diseases: the DNDi model

    Drug discovery and development for neglected diseases: the DNDi model by Eric Chatelain, Jean-Robert Ioset

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis

    Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis by Katrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, Mo Alavijeh, Stéphanie Braillard, Charles E. Mowbray, Simon L. Croft

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Antibacterial and Antibiofilm Properties of the Alexidine Dihydrochloride (MMV396785) against <i>Acinetobacter baumannii</i>

    Antibacterial and Antibiofilm Properties of the Alexidine Dihydrochloride (MMV396785) against <i>Acinetobacter baumannii</i> by Kirti Upmanyu, Qazi Mohd. Rizwanul Haq, Ruchi Singh

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Translational challenges of animal models in Chagas disease drug development: a review

    Translational challenges of animal models in Chagas disease drug development: a review by Chatelain E, Konar N

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development.

    Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis... by María Del Mar Castro, Astrid C Erber, Byron Arana, Gláucia Cota, Claudia M Denkinger, Nicole Harrison, Julia Kutyi, Liliana López-Carvajal, Emma Plugge, Julia Walochnik, Piero Olliaro

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation.

    Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation. by Jaime Altcheh, Guillermo Moscatelli, Martin Caruso, Samanta Moroni, Margarita Bisio, Maria Rosa Miranda, Celia Monla, Maria Vaina, Maria Valdez, Lucrecia Moran, Teresa Ramirez, Oscar Ledesma Patiño, Adelina Riarte, Nicolas Gonzalez, Jayme Fernandes, Fabiana Alves, Isabela Ribeiro, Facundo Garcia-Bournissen

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.

    Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh. by Ridwanur Rahman, Vishal Goyal, Rashidul Haque, Kazi Jamil, Abul Faiz, Rasheda Samad, Sally Ellis, Manica Balasegaram, Margriet den Boer, Suman Rijal, Nathalie Strub-Wourgaft, Fabiana Alves, Jorge Alvar, Bhawna Sharma

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.

    Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. by Els Torreele, Bernadette Bourdin Trunz, David Tweats, Marcel Kaiser, Reto Brun, Guy Mazué, Michael A Bray, Bernard Pécoul

    Published 2010
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: